Activating NLRP3 selectively in atrial cardiomyocytes is sufficient to promote atrial structural remodeling (atrial hypertrophy), spontaneous premature atrial contractions, and inducible AF (86). The gene discussed is NLRP3; the disease is atrial fibrillation.